rMark Bio, Inc. is a software company based in Chicago, IL.

rMark Bio's industry leading AI solution understands the real-time business strategies of R&D, Medical Affairs, Marketing, and Commercial to provide field representatives with clear and concise 'next best decisions' that remove inefficiencies and increase ROI for thought leader engagements.


Our leadership team consists of business, biochemist, product design and development veterans with proven track records of success supported by a team of accomplished software engineers, data scientists and designers.

Jason M. Smith

Co-Founder & Chief Executive Officer

Jason Smith is a seasoned entrepreneur with over 17 years of industry experience as technologist and product executive . He has held positions in early-stage companies, large multi-national corporations and venture capital incubators yielding a rich professional background. He has assisted multiple startups to raise over $5MM in funding. Jason brings experience as an business executive and principal technologist in distributed systems architecture, big data analytics, and high-performance computing from work with ATI Research, AT&T, General Dynamics, IBM and GraySky Simulations.

Lev Becker, PHD

Co-Founder & Chief Science Officer

A tenure-track Assistant Professor at the University of Chicago, Lev’s research, which has been published in prominent journals including Cell Metabolism, Immunity, and PNAS, routinely incorporates systems biology, computational, and bioinformatics methods. His expertise in these areas is underscored by the numerous research grants he as obtained from the National Institutes of Health, American Heart Association, Cancer Research Foundation, and ResMed Corporation.

Brian Ganaway

VP of Tech Ops

Brian Ganaway has over 10 years experience in multiple facets of end-to-end customer architecture, contracted services, business services, and product delivery. He recently worked for CDW as a Lead Customer Service Architect wherein one of his key responsibilities included the development and implementation of a multi-billion dollar Managed Services program for their Fortune 500 clients. Brian’s experience blends hands-on technical expertise and executive leadership as highlighted by his roles at Watermark Estate Management, 1st United Bank, and ITS.

Joe Bangah

VP of Finance

Joe Bangah has held executive positions at several telecommunications industry companies, focusing on business model development, financial analytics, operational budget management, fund raising and M&A activities, including Spligitty Fiber Optic Services and CondoInternet (acquired by Wave Broadband). Joe holds a Bachelor of Applied Science degree from University of British Columbia and a Master of Business Administration degree from University of Washington.

Jason Nett, PHD

Director of Data Science

Jason Nett began his career as an experimental high energy physicist, earning a Ph.D. from the University of Wisconsin-Madison and going on to perform research in finding evidence for the Higgs Boson, searches for supersymmetry, and precision measurements in electroweak physics. He then spent years as a full stack software engineer building the data program for a company that provides inflight connectivity. He designed and built software deriving business value out of data, online reporting systems, and an online advertising platform. In both the academic and private sectors, he has developed and utilized cutting edge data science and AI techniques in software.

“One of the more unique things about the rMark Bio team is that we are a group of individuals with deep experience and successes from various fields coming together with a common goal. Combining our different perspectives has already lead to amazing innovations. I cannot wait to see what happens next."

Jason M. Smith

Co-Founder & CEO

Advisory Board

rMark Bio advisors provide diverse expertise in finance, business strategies, and the pharmaceutical industry.

Gayle Kirkpatrick, PharmaD, CLP

VP Licensing & Acquisitions, AbbVie

Stuart Depina

Group President Envestnet | Tamarac

Dr. Christopher Rhodes

Vice President, Cardiovascular and Metabolic Disease R&D, MedImmune